We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
On this first trading day for the month of April, certain aspects of the market feel like the beginning of something: along with the hopes of warmer weather and the crack of the baseball bat sounding in parks all across the country, we are anticipating another strong quarter of growth as Q1 earnings season starts in the next couple weeks. At the end of this week, we’ll see the latest non-farm payroll report from the Bureau of Labor Statistics (BLS).
Before this, however, we’ll see the latest private sector payroll reports from ADP (ADP - Free Report) released before the opening bell this Wednesday. Last month, ADP posted nearly 300K private-sector jobs, which was much higher than analysts had expected. Growth in Construction and Manufacturing surprised to the upside, with Goods employment up triple-digits for the first time in a very long time. We shall see if this continues as the Trump Era moves along in its still-early stages.
This week also brings along some early Q1 earnings reports, including Monsanto and Walgreens Boots Alliance (WBA - Free Report) on Wednesday. Monsanto is currently a Zacks Rank #2 (Buy) stock with a Zacks Style Score (Value, Growth, Momentum) of B. Walgreens also has a Zacks Style Score of B, with a Zacks Rank #3 (Hold).
For comprehensive coverage of earnings season both in its current nascent stages as well as when reporting heats up, we’d all do well to follow what Zacks Director of Research Sheraz Mian has to say about it. For his latest Earnings Preview, click here: Handicapping Q1 Earnings Season. https://www.zacks.com/commentary/108341/handicapping-the-q1-earnings-season
Image: Bigstock
Plenty to Look Forward To
Monday, April 3, 2017
On this first trading day for the month of April, certain aspects of the market feel like the beginning of something: along with the hopes of warmer weather and the crack of the baseball bat sounding in parks all across the country, we are anticipating another strong quarter of growth as Q1 earnings season starts in the next couple weeks. At the end of this week, we’ll see the latest non-farm payroll report from the Bureau of Labor Statistics (BLS).
Before this, however, we’ll see the latest private sector payroll reports from ADP (ADP - Free Report) released before the opening bell this Wednesday. Last month, ADP posted nearly 300K private-sector jobs, which was much higher than analysts had expected. Growth in Construction and Manufacturing surprised to the upside, with Goods employment up triple-digits for the first time in a very long time. We shall see if this continues as the Trump Era moves along in its still-early stages.
This week also brings along some early Q1 earnings reports, including Monsanto and Walgreens Boots Alliance (WBA - Free Report) on Wednesday. Monsanto is currently a Zacks Rank #2 (Buy) stock with a Zacks Style Score (Value, Growth, Momentum) of B. Walgreens also has a Zacks Style Score of B, with a Zacks Rank #3 (Hold).
For comprehensive coverage of earnings season both in its current nascent stages as well as when reporting heats up, we’d all do well to follow what Zacks Director of Research Sheraz Mian has to say about it. For his latest Earnings Preview, click here: Handicapping Q1 Earnings Season. https://www.zacks.com/commentary/108341/handicapping-the-q1-earnings-season
Mark Vickery
Senior Editor
Questions or comments about this article and/or its author? Click here>>